Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.27 | 1.94 |
NAV | ₹31.57 | ₹437.40 |
Fund Started | 20 Jun 2019 | 04 Jun 1999 |
Fund Size | ₹890.33 Cr | ₹3628.03 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 29.86% | 37.78% |
3 Year | 18.00% | 23.84% |
5 Year | 24.01% | 29.48% |
1 Year
3 Year
5 Year
Equity | 97.82% | 96.50% |
Cash | 2.18% | 3.50% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 14.31% |
Cipla Ltd. | 9.01% |
Torrent Pharmaceuticals Ltd. | 8.35% |
Apollo Hospitals Enterprise Ltd. | 5.91% |
Fortis Healthcare Ltd. | 5.61% |
Aurobindo Pharma Ltd. | 5.04% |
Lupin Ltd. | 4.71% |
Ajanta Pharma Ltd. | 4.58% |
Ipca Laboratories Ltd. | 3.98% |
Alkem Laboratories Ltd. | 3.29% |
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 12.87% |
Divi's Laboratories Ltd. | 6.42% |
Cipla Ltd. | 5.68% |
Max Healthcare Institute Ltd. | 5.66% |
Lupin Ltd. | 4.74% |
Lonza Group Ag | 4.39% |
Poly Medicure Ltd. | 4.02% |
Krishna Institute of Medical Sciences Ltd | 3.75% |
Jupiter Life Line Hospitals Ltd. | 3.64% |
Aether Industries Ltd. | 3.33% |
Name | Dhaval Joshi | Tanmaya Desai |
Start Date | 21 Nov 2022 | 27 Jun 2011 |
Name
Start Date
Description | The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 20 Jun 2019 | 04 Jun 1999 |
Description
Launch Date